Innovative diagnostic tools for early detection of Alzheimer's disease

Alzheimer's and Dementia

Volumn 11, Issue 5, 2015, Pages 561-578

  Laske, Christoph ^a,b   Sohrabi, Hamid R ^c,d   Frost, Shaun M ^e   López De Ipiña, Karmele ^f   Garrard, Peter ^g   Buscema, Massimo ^h,i   Dauwels, Justin ^j   Soekadar, Surjo R ^a   Mueller, Stephan ^a   Linnemann, Christoph ^a   Bridenbaugh, Stephanie A ^k   Kanagasingam, Yogesan ^e   Martins, Ralph N ^c,d   O'bryant, Sid E ^l  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c EDITH COWAN UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e CSIRO   (Australia)

^f UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^g ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^h Semeion centro ricerche di scienze della communicazione   (Italy)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^k Felix Platter Spital   (Switzerland)

^l University of North Texas Health Science Center   (United States)

more..

Author keywords

Alzheimer's disease; Diagnostic tools; Early detection; Noninvasive tests; Screening tests

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; CLINICAL PRACTICE; COGNITIVE DEFECT; COST; DEMENTIA; ELECTROENCEPHALOGRAM; GAIT; HUMAN; MEMORY; NEUROPHYSIOLOGICAL MONITORING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SOCIOECONOMICS; SPEECH; BLOOD; COMPLICATION; DEPRESSION; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ELECTROPHYSIOLOGY; EYE; MEMORY DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STANDARDS;

ALZHEIMER DISEASE; DEPRESSION; DIAGNOSTIC TESTS, ROUTINE; EARLY DIAGNOSIS; ELECTROPHYSIOLOGY; EYE; GAIT; HUMANS; MEMORY DISORDERS;

EID: 84929264128     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.06.004     Document Type: Review

References (194)

1. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N Engl J Med 362 2010 329 344
2. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch Neurol 60 2003 1119 1122
3. C. Laske Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease N Engl J Med 370 2014 1459
4. C.R. Jack, M.S. Albert, D.S. Knopman, G.M. McKhann, R.A. Sperling, and M.C. Carrillo Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 257 262
5. A. Connolly, E. Gaehl, H. Martin, J. Morris, and N. Purandare Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence Aging Ment Health 15 2011 978 984
6. H.J. Aizenstein, R.D. Nebes, J.A. Saxton, J.C. Price, C.A. Mathis, and N.D. Tsopelas Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 2008 1509 1517
7. J.L. Price, D.W. McKeel, V.D. Buckles, C.M. Roe, C. Xiong, and M. Grundman Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease Neurobiol Aging 30 2009 1026 1036
8. G. De Meyer, F. Shapiro, H. Vanderstichele, E. Vanmechelen, S. Engelborghs, and P.P. De Deyn Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people Arch Neurol 67 2010 949 956
9. American Geriatrics Society Geriatrics Workforce Policy Studies Center. http://www.adgapstudy.uc.edu/index.cfm/ Accessed March 9, 2012.
10. J.H. Scully, and J.E. Wilk Selected characteristics and data of psychiatrists in the United States, 2001-2002 2003 Academic Psychiatry
11. American Academy of Neurology. http://www.aan.com/go/about/statistics/ Accessed May 5, 2011.
12. P. Rinck Magnetic resonance in medicine. The basic textbook of the European Magnetic Resonance Forum 7th ed 2013 Electronic version 7.1 1 October 2013
13. N. Acosta-Baena, D. Sepulveda-Falla, C.M. Lopera-Gómez, M.C. Jaramillo-Elorza, S. Moreno, and D.C. Aguirre-Acevedo Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study Lancet Neurol 10 2011 213 220
14. L. Bäckman, S. Jones, A.-K. Berger, E.J. Laukka, and B.J. Small Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis Neuropsychology 19 2005 520 531
15. H. Abikoff, J. Alvir, G. Hong, R. Sukoff, J. Orazio, and S. Solomon Logical memory subtest of the Wechsler Memory Scale: age and education norms and alternate-form reliability of two scoring systems J Clin Exp Neuropsychol 9 1987 435 448
16. D.C. Delis, J.H. Kramer, E. Kaplan, and B.A. Ober California Verbal Learning Test - Second Edition (CVLT®-II) 2000 Psychological Cooperation TX
17. E. Grober, R.B. Lipton, C. Hall, and H. Crystal Memory impairment on free and cued selective reminding predicts dementia Neurology 54 2000 827 832
18. I.R. Beck, A. Gagneux-Zurbriggen, M. Berres, K.I. Taylor, and A.U. Monsch Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease - Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT) Arch Clin Neuropsychol 27 2012 510 519
19. C.A. Derby, L.C. Burns, C. Wang, M.J. Katz, M.E. Zimmerman, and G. L'Italien Screening for predementia AD: time-dependent operating characteristics of episodic memory tests Neurology 80 2013 1307 1314
20. M. Sarazin, C. Berr, J. De Rotrou, C. Fabrigoule, F. Pasquier, and S. Legrain Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study Neurology 69 2007 1859 1867
21. M. Wagner, S. Wolf, F.M. Reischies, M. Daerr, S. Wolfsgruber, and F. Jessen Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease Neurology 78 2012 379 386
22. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-Mental State 1975
23. J.C. Morris, C. Ernesto, K. Schafer, M. Coats, S. Leon, and M. Sano Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience Neurology 48 1997 1508 1510
24. R.J. Bateman, C. Xiong, T.L. Benzinger, A.M. Fagan, A. Goate, and N.C. Fox Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
25. J.C. Morris, S. Weintraub, H.C. Chui, J. Cummings, C. Decarli, and S. Ferris The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers Alzheimer Dis Assoc Disord 20 2006 210 216
26. M.F. Elias, A. Beiser, P.A. Wolf, R. Au, R.F. White, and R.B. D'Agostino The preclinical phase of alzheimer disease: a 22-year prospective study of the Framingham Cohort Arch Neurol 57 2000 808 813
27. M.I. Geerlings, C. Jonker, L.M. Bouter, H.J. Adèr, and B. Schmand Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition Am J Psychiatry 156 1999 531 537
28. F. Jessen, B. Wiese, C. Bachmann, S. Eifflaender-Gorfer, F. Haller, and H. Kölsch Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment Arch Gen Psychiatry 67 2010 414 422
29. O. Juncos-Rabadán, A.X. Pereiro, D. Facal, C. Lojo, J.A. Caamaño, and J. Sueiro Prevalence and correlates of mild cognitive impairment in adults aged over 50 years with subjective cognitive complaints in primary care centers Geriatr Gerontol Int 2013
30. D.E. Broadbent, P.F. Cooper, P. FitzGerald, and K.R. Parkes The cognitive failures questionnaire (CFQ) and its correlates Br J Clin Psychol 21 Pt 1 1982 1 16
31. T.J. Hohman, L.L. Beason-Held, M. Lamar, and S.M. Resnick Subjective cognitive complaints and longitudinal changes in memory and brain function Neuropsychology 25 2011 125 130
32. R.C. Kessler, P. Berglund, O. Demler, R. Jin, and E.E. Walters Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication Arch Gen Psychiatry 62 2005 593 602
33. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, and M. Ganguli Global prevalence of dementia: a Delphi consensus study Lancet 366 2005 2112 2117
34. D.J. Vinkers, J. Gussekloo, M.L. Stek, R.G. Westendorp, and R.C. van der Mast Temporal relation between depression and cognitive impairment in old age: prospective population based study Bmj 329 2004 881
35. J.M. Ringman, C. Diaz-Olavarrieta, Y. Rodriguez, M. Chavez, F. Paz, and J. Murrell Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin J Neurol Neurosurg Psychiatr 75 2004 500 502
36. R.S. Wilson, L.L. Barnes, C.F. Mendes de Leon, N.T. Aggarwal, J.S. Schneider, and J. Bach Depressive symptoms, cognitive decline, and risk of AD in older persons Neurology 59 2002 364 370
37. J.L. Gatz, S.L. Tyas, P.S. John, and P. Montgomery Do depressive symptoms predict Alzheimer's disease and dementia? J Gerontol a Biol Sci Med Sci 60 2005 744 747
38. R.L. Ownby, E. Crocco, A. Acevedo, V. John, and D. Loewenstein Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis Arch Gen Psychiatry 63 2006 530 538
39. F. Irie, K.H. Masaki, H. Petrovitch, R.D. Abbott, G.W. Ross, and D.R. Taaffe Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study Arch Gen Psychiatry 65 2008 906 912
40. R. Chen, Z. Hu, L. Wei, X. Qin, C. McCracken, and J.R. Copeland Severity of depression and risk for subsequent dementia: cohort studies in China and the UK Br J Psychiatry 193 2008 373 377
41. A.L. Byers, and K. Yaffe Depression and risk of developing dementia Nat Rev Neurol 7 2011 323 331
42. D.E. Barnes, K. Yaffe, A.L. Byers, M. McCormick, C. Schaefer, and R.A. Whitmer Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia Arch Gen Psychiatry 69 2012 493 498
43. K. Heser, F. Tebarth, B. Wiese, M. Eisele, H. Bickel, and M. Koehler Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe) Psychol Med 43 2013 1597 1610
44. P.J. Chen, M. Ganguli, B.H. Mulsant, and S.T. DeKosky The temporal relationship between depressive symptoms and dementia - a community-based prospective study Arch Gen Psychiatry 56 1999 261 266
45. H. Lavretsky, L. Ercoli, P. Siddarth, S. Bookheimer, K. Miller, and G. Small Apolipoprotein epsilon 4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia Am J Geriatr Psychiatry 11 2003 667 673
46. A.J. Mitchell Depression as a risk factor for later dementia: a robust relationship? Age Ageing 34 2005 207 209
47. J.A. Brommelhoff, M. Gatz, B. Johansson, J.J. McArdle, L. Fratiglioni, and N.L. Pedersen Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins Psychology and Aging 24 2009 373 384
48. J.L. Wetherell, M. Gatz, B. Johansson, and N.L. Pedersen History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample Alzheimer Dis Assoc Disord 13 1999 47 52
49. M. Faundez-Zanuy, A. Hussain, J. Mekyska, E. Sesa-Nogueras, E. Monte-Moreno, and A. Esposito Biometric applications related to human beings: there is life beyond security Cogn Comput 5 2013 136 151
50. K. Lopez-de-Ipina, J.-B. Alonso, C. Manuel Travieso, J. Sole-Casals, H. Egiraun, and M. Faundez-Zanuy On the selection of non-invasive methods based on speech analysis oriented to automatic Alzheimer disease diagnosis Sensors (Basel) 13 2013 6730 6745
51. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., and C.H. Kawas The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
52. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
53. K. Horley, A. Reid, and D. Burnham Emotional prosody perception and production in dementia of the Alzheimer's type J Speech Lang Hear Res 53 2010 1132 1146
54. M. Lehr, E.T. Prud'hommeaux, I. Shafran, and B. Roark Fully automated neuropsychological assessment for detecting mild cognitive impairment 2012 Spoken Language Processing and Biomedicine Interspeech 2012
55. K. Lopez-de-Ipiña, J.B. Alonso, J. Solé-Casals, N. Barroso, P. Henriquez, and M. Faundez-Zanuy On automatic diagnosis of Alzheimer's disease based on spontaneous speech analysis and emotional temperature Cogn Comput 2013
56. K.E. Forbes, A. Venneri, and M.F. Shanks Distinct patterns of spontaneous speech deterioration: an early predictor of Alzheimer's disease Brain Cogn 48 2002 356 361
57. S.V.S. Pakhomov, L.S. Hemmy, and K.O. Lim Automated semantic indices related to cognitive function and rate of cognitive decline Neuropsychologia 50 2012 2165 2175
58. A. Weakley, M. Schmitter-Edgecombe, and J. Anderson Analysis of verbal fluency ability in amnestic and non-amnestic mild cognitive impairment Arch Clin Neuropsychol 28 2013 721 731
59. V. Baldas, C. Lampiris, C. Capsalis, and D. Koutsouris Early diagnosis of Alzheimer's type dementia using continuous speech recognition. Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering 55 2011 Springer Berlin Heidelberg Berlin, Heidelberg 105 110
60. Fraser K, Rudzicz F, Graham N, Rochon E. Automatic speech recognition in the diagnosis of primary progressive aphasia. Proceedings of the Fourth Workshop on Speech and Language Processing for Assistive Technologies/SPLAT2013), 21-22 August, Grenoble, France 2013.
61. P. Garrard, and J.R. Hodges Semantic dementia: clinical, radiological and pathological perspectives J Neurol 247 2000 409 422
62. M. Grossman, J. Mickanin, K. Onishi, E. Hughes, M. D'Esposito, and X.S. Ding Progressive nonfluent aphasia: language, cognitive, and PET measures contrasted with probable Alzheimer's disease J Cogn Neurosci 8 1996 135 154
63. M.L. Henry, and M.L. Gorno-Tempini The logopenic variant of primary progressive aphasia Curr Opin Neurol 23 2010 633 637
64. S.M. Wilson, M.L. Henry, M. Besbris, J.M. Ogar, N.F. Dronkers, and W. Jarrold Connected speech production in three variants of primary progressive aphasia Brain 133 2010 2069 2088
65. E.M. Saffran, R.S. Berndt, and M.F. Schwartz The quantitative analysis of agrammatic production: procedure and data Brain Lang 37 1989 440 479
66. P. Garrard, V. Rentoumi, B. Gesierich, B. Miller, and M.L. Gorno-Tempini Machine learning approaches to diagnosis and laterality effects in semantic dementia discourse Cortex 55 2014 122 129
67. K.C. Fraser, J.A. Meltzer, N.L. Graham, C. Leonard, G. Hirst, and S.E. Black Automated classification of primary progressive aphasia subtypes from narrative speech transcripts Cortex 55 2014 43 60
68. M. Serby, J. Corwin, P. Conrad, and J. Rotrosen Olfactory dysfunction in Alzheimer's disease and Parkinsons disease Am J Psychiatry 142 1985 781 782
69. M.D. Warner, C.A. Peabody, J.J. Flattery, and J.R. Tinklenberg Olfactory deficits and Alzheimer's disease Biol Psychiatry 21 1986 116 118
70. C.R. Schubert, L.L. Carmichael, C. Murphy, B.E. Klein, R. Klein, and K.J. Cruickshanks Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults J Am Geriatr Soc 56 2008 1517 1521
71. R.S. Wilson, J.A. Schneider, S.E. Arnold, Y. Tang, P.A. Boyle, and D.A. Bennett Olfactory identification and incidence of mild cognitive impairment in older age Arch Gen Psychiatry 64 2007 802 808
72. C. Murphy, A.W. Bacon, M.W. Bondi, and D.P. Salmon Apolipoprotein E status is associated with odor identification deficits in nondemented older personsa Ann N Y Acad Sci 855 1998 744 750
73. D.P. Devanand, K.S. Michaels-Marston, X. Liu, G.H. Pelton, M. Padilla, and K. Marder Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up Am J Psychiatry 157 2000 1399 1405
74. H.R. Sohrabi, K.A. Bates, M. Rodrigues, K. Taddei, S.M. Laws, and N.T. Lautenschlager Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals J Alzheimers Dis 17 2009 135 142
75. R.S. Wilson, S.E. Arnold, J.A. Schneider, P.A. Boyle, A.S. Buchman, and D.A. Bennett Olfactory impairment in presymptomatic Alzheimer's disease Ann N Y Acad Sci 1170 2009 730 735
76. H.R. Sohrabi, K.A. Bates, M.G. Weinborn, A.N. Johnston, A. Bahramian, and K. Taddei Olfactory discrimination predicts cognitive decline among community-dwelling older adults Transl Psychiatry 2 2012 e118
77. C.D. Morgan, and C. Murphy Olfactory event-related potentials in Alzheimer's disease J Int Neuropsychol Soc 8 2002 753 763
78. S.S. Schiffman, and C.A. Gatlin Clinical physiology of taste and smell Ann Rev Nutr 13 1993 405 436
79. T. Tanabe, M. Iino, and S.F. Takagi Discrimination of odors in olfactory bulb, pyriform-amygdaloid areas, and orbitofrontal cortex of the monkey J Neurophysiol 38 1975 1284 1296
80. T.G. Ohm, and H. Braak Olfactory bulb changes in Alzheimer's disease Acta Neuropathol 73 1987 365 369
81. P. Averback Two new lesions in Alzheimer's disease Lancet 2 1983 1203
82. T. Kovács, N.J. Cairns, and P.L. Lantos beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease Neuropathol Appl Neurobiol 25 1999 481 491
83. D.W. Wesson, E. Levy, R.A. Nixon, and D.A. Wilson Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model J Neurosci 30 2010 505 514
84. A. Eibenstein, A.B. Fioretti, C. Lena, N. Rosati, G. Amabile, and M. Fusetti Modern psychophysical tests to assess olfactory function Neurol Sci 26 2005 147 155
85. R.L. Doty Office procedures for quantitative assessment of olfactory function Am J Rhinol 21 2007 460 473
86. R.S. Herz, and T. Engen Odor memory: review and analysis Psychon Bull Rev 3 1996 300 313
87. P.W. Schofield, H. Ebrahimi, A.L. Jones, G.A. Bateman, and S.R. Murray An olfactory 'stress test' may detect preclinical Alzheimer's disease BMC Neurol 12 2012 24
88. R.I. Mesholam, P.J. Moberg, R.N. Mahr, and R.L. Doty Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases Arch Neurol 55 1998 84 90
89. J. Lehrner, C. Baumgartner, W. Serles, A. Olbrich, E. Pataraia, and J. Bacher Olfactory prodromal symptoms and unilateral olfactory dysfunction are associated in patients with right mesial temporal lobe epilepsy Epilepsia 38 1997 1042 1044
90. R.L. Doty, M.B. Stern, C. Pfeiffer, S.M. Gollomp, and H.I. Hurtig Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease J Neurol Neurosurg Psychiatr 55 1992 138 142
91. B.M. Pause, A. Miranda, R. Göder, J.B. Aldenhoff, and R. Ferstl Reduced olfactory performance in patients with major depression J Psychiatr Res 35 2001 271 277
92. R. Elsner Odor memory and aging Aging 8 2001 284 306
93. R.L. Doty, P. Shaman, S.L. Applebaum, R. Giberson, L. Siksorski, and L. Rosenberg Smell identification ability - changes with age Science 226 1984 1441 1443
94. L. Velayudhan, M. Pritchard, J.F. Powell, P. Proitsi, and S. Lovestone Smell identification function as a severity and progression marker in Alzheimer's disease Int Psychogeriatr 25 2013 1157 1166
95. T. Kovács The olfactory system in Alzheimer's disease: pathology, pathophysiology and pathway for therapy Transl Neurosci 4 2013 34 45
96. M.W. Albers, M.H. Tabert, and D.P. Devanand Olfactory dysfunction as a predictor of neurodegenerative disease Curr Neurol Neurosci Rep 6 2006 379 386
97. R. Schliebs, and T. Arendt The significance of the cholinergic system in the brain during aging and in Alzheimer's disease J Neural Transm Gen Sect 113 2006 1625 1644
98. B. Katz, and S. Rimmer Ophthalmologic manifestations of Alzheimer's disease Surv Ophthalmol 34 1989 31 43
99. A.A. Sadun, M. Borchert, E. DeVita, D.R. Hinton, and C.J. Bassi Assessment of visual impairment in patients with Alzheimer's disease Am J Ophthalmol 104 1987 113 120
100. K.W. Whittaker, M.A. Burdon, and P. Shah Visual field loss and Alzheimer's disease Eye (Lond) 16 2002 206 208
101. M. Pache, C.H. Smeets, P.F. Gasio, E. Savaskan, J. Flammer, and A. Wirz-Justice Colour vision deficiencies in Alzheimer's disease Age Ageing 32 2003 422 426
102. R.W. Crow, L.B. Levin, L. LaBree, R. Rubin, and S.E. Feldon Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementia Invest Ophthalmol Vis Sci 44 2003 875 878
103. G. Schlotterer, M. Moscovitch, and D. Crapper-McLachlan Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease Brain 107 Pt 1 1984 309 325
104. R. Mielke, J. Kessler, G. Fink, K. Herholz, and W.D. Heiss Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease Int J Neurosci 82 1995 1 9
105. F. Berisha, G.T. Feke, C.L. Trempe, J.W. McMeel, and C.L. Schepens Retinal abnormalities in early Alzheimer's disease Invest Ophthalmol Vis Sci 48 2007 2285 2289
106. C. Paquet, M. Boissonnot, F. Roger, P. Dighiero, R. Gil, and J. Hugon Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease Neurosci Lett 420 2007 97 99
107. S. Frost, Y. Kanagasingam, H. Sohrabi, J. Vignarajan, P. Bourgeat, and O. Salvado Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease Transl Psychiatry 3 2013 e233
108. D.F. Fotiou, C.G. Brozou, A.-B. Haidich, D. Tsiptsios, M. Nakou, and A. Kabitsi Pupil reaction to light in Alzheimer's disease: evaluation of pupil size changes and mobility Aging Clin Exp Res 19 2007 364 371
109. E. Granholm, S. Morris, D. Galasko, C. Shults, E. Rogers, and B. Vukov Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease Int J Psychophysiol 47 2003 95 115
110. S. Frost, Y. Kanagasingam, H. Sohrabi, P. Bourgeat, V. Villemagne, and C.C. Rowe Pupil response biomarkers for early detection and monitoring of Alzheimer's disease Curr Alzheimer Res 10 2013 931 939
111. H.V. Danesh-Meyer, H. Birch, J.Y. Ku, S. Carroll, and G. Gamble Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging Neurology 67 2006 1852 1854
112. A.A. Sadun, and C.J. Bassi Optic nerve damage in Alzheimer's disease Ophthalmology 97 1990 9 17
113. J.C. Blanks, Y. Torigoe, D.R. Hinton, and R.H. Blanks Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina Neurobiol Aging 17 1996 377 384
114. R. Prettyman, P. Bitsios, and E. Szabadi Altered pupillary size and darkness and light reflexes in Alzheimer's disease J Neurol Neurosurg Psychiatr 62 1997 665 668
115. F.J. de Jong, E.M. Schrijvers, M.K. Ikram, P.J. Koudstaal, P.T. de Jong, and A. Hofman Retinal vascular caliber and risk of dementia The Rotterdam Study Neurology 76 2011 816 821
116. S.M. Frost, Y. Kanagasingam, H.R. Sohrabi, K. Taddei, R. Bateman, and J. Morris Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers Curr Alzheimer Res 10 2013 790 796
117. M. Koronyo-Hamaoui, Y. Koronyo, A.V. Ljubimov, C.A. Miller, M.K. Ko, and K.L. Black Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model Neuroimage 54 Suppl 1 2011 S204 S217
118. L.E. Goldstein, J.A. Muffat, R.A. Cherny, R.D. Moir, M.H. Ericsson, and X. Huang Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease Lancet 361 2003 1258 1265
119. S. Bridenbaugh, A.U. Monsch, and R.W. Kressig How does gait change as cognitive decline progresses in the elderly? Alzheimers Dement 8 2012 P131 P132
120. J. Verghese, C. Wang, R.B. Lipton, R. Holtzer, and X. Xue Quantitative gait dysfunction and risk of cognitive decline and dementia J Neurol Neurosurg Psychiatr 78 2007 929 935
121. M.M. Mielke, R.O. Roberts, R. Savica, R. Cha, D.I. Drubach, and T. Christianson Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging J Gerontol a Biol Sci Med Sci 68 2013 929 937
122. J. Verghese, C. Wang, R.B. Lipton, and R. Holtzer Motoric cognitive risk syndrome and the risk of dementia J Gerontol a Biol Sci Med Sci 68 2013 412 418
123. J.M. Hausdorff, and A.S. Buchman What links gait speed and MCI with dementia? A fresh look at the association between motor and cognitive function J Gerontol a Biol Sci Med Sci 68 2013 409 411
124. S.A. Bridenbaugh, and R.W. Kressig Quantitative gait disturbances in older adults with cognitive impairments Curr Pharm Des 2013
125. J.E. Wittwer, K.E. Webster, and H.B. Menz A longitudinal study of measures of walking in people with Alzheimer's disease Gait Posture 32 2010 113 117
126. S.A. Bridenbaugh, and R.W. Kressig Laboratory review: the role of gait analysis in seniors' mobility and fall prevention Gerontology 57 2011 256 264
127. M. Montero-Odasso, S.W. Muir, and M. Speechley Dual-task complexity affects gait in people with mild cognitive impairment: the interplay between gait variability, dual tasking, and risk of falls Arch Phys Med Rehabil 93 2012 293 299
128. O. Beauchet, G. Allali, G. Berrut, C. Hommet, V. Dubost, and F. Assal Gait analysis in demented subjects: Interests and perspectives Neuropsychiatr Dis Treat 4 2008 155 160
129. P. Fuentes Clinical diagnosis in preclinical stage of Alzheimer's disease Arch Med Res 43 2012 667 670
130. J.E. Wittwer, K.E. Webster, and K. Hill The effects of a concurrent motor task on walking in Alzheimer's disease Gait Posture 39 2014 291 296
131. R. Holtzer, C. Wang, and J. Verghese Performance variance on walking while talking tasks: theory, findings, and clinical implications Age (Dordr) 2013
132. N. Theill, M. Martin, V. Schumacher, S.A. Bridenbaugh, and R.W. Kressig Simultaneously measuring gait and cognitive performance in cognitively healthy and cognitively impaired older adults: the Basel motor-cognition dual-task paradigm J Am Geriatr Soc 59 2011 1012 1018
133. B.D. Zipser, C.E. Johanson, L. Gonzalez, T.M. Berzin, R. Tavares, and C.M. Hulette Microvascular injury and blood-brain barrier leakage in Alzheimer's disease Neurobiol Aging 28 2007 977 986
134. J.K. Ryu, and J.G. McLarnon A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain J Cell Mol Med 13 2009 2911 2925
135. M. Kivipelto, T. Ngandu, T. Laatikainen, B. Winblad, H. Soininen, and J. Tuomilehto Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study Lancet Neurol 5 2006 735 741
136. N.R. Graff-Radford, J.E. Crook, J. Lucas, B.F. Boeve, D.S. Knopman, and R.J. Ivnik Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease Arch Neurol 64 2007 354 362
137. K. Yaffe, A. Weston, N.R. Graff-Radford, S. Satterfield, E.M. Simonsick, and S.G. Younkin Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline JAMA 305 2011 261 266
138. R. Schmidt, H. Schmidt, J.D. Curb, K. Masaki, L.R. White, and L.J. Launer Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study Ann Neurol 52 2002 168 174
139. M. van Oijen, J.C. Witteman, A. Hofman, P.J. Koudstaal, and M.M.B. Breteler Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia Stroke 36 2005 2637 2641
140. Z.S. Tan, A.S. Beiser, R.S. Vasan, R. Roubenoff, C.A. Dinarello, and T.B. Harris Inflammatory markers and the risk of Alzheimer disease: the Framingham Study Neurology 68 2007 1902 1908
141. E. van Exel, P. Eikelenboom, H. Comijs, M. Frölich, J.H. Smit, and M.L. Stek Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease Arch Gen Psychiatry 66 2009 1263 1270
142. M. Mapstone, A.K. Cheema, M.S. Fiandaca, X. Zhong, T.R. Mhyre, and L.H. Macarthur Plasma phospholipids identify antecedent memory impairment in older adults Nat Med 20 2014 415 418
143. S. Ray, M. Britschgi, C. Herbert, Y. Takeda-Uchimura, A. Boxer, and K. Blennow Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Nat Med 13 2007 1359 1362
144. S.E. O'Bryant, G. Xiao, R. Barber, J. Reisch, R. Doody, and T. Fairchild A serum protein-based algorithm for the detection of Alzheimer disease Arch Neurol 67 2010 1077 1081
145. C. Laske, T. Leyhe, E. Stransky, N. Hoffmann, A.J. Fallgatter, and J. Dietzsch Identification of a blood-based biomarker panel for classification of Alzheimer's disease Int J Neuropsychopharmacol 14 2011 1147 1155
146. H.D. Soares, W.Z. Potter, E. Pickering, M. Kuhn, F.W. Immermann, and D.M. Shera Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease Arch Neurol 69 2012 1310 1317
147. J.D. Doecke, S.M. Laws, N.G. Faux, W. Wilson, S.C. Burnham, and C.-P. Lam Blood-based protein biomarkers for diagnosis of Alzheimer disease Arch Neurol 69 2012 1318 1325
148. W.T. Hu, D. Holtzman, L. Shaw, J. Trojanowski, and H. Soares Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease Neurology 80 2013 690 691
149. R.A. Sperling, P.S. Laviolette, K. O'Keefe, J. O'Brien, D.M. Rentz, and M. Pihlajamaki Amyloid deposition is associated with impaired default network function in older persons without dementia Neuron 63 2009 178 188
150. Y.I. Sheline, M.E. Raichle, A.Z. Snyder, J.C. Morris, D. Head, and S. Wang Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly Biol Psychiatry 67 2010 584 587
151. M. Steriade Grouping of brain rhythms in corticothalamic systems Neuroscience 137 2006 1087 1106
152. P. Anderer, B. Saletu, B. Klöppel, H.V. Semlitsch, and H. Werner Discrimination between demented patients and normals based on topographic EEG slow wave activity: comparison between z statistics, discriminant analysis and artificial neural network classifiers Electroencephalogr Clin Neurophysiol 91 1994 108 117
153. C. Besthorn, R. Zerfass, C. Geiger-Kabisch, H. Sattel, S. Daniel, and U. Schreiter-Gasser Discrimination of Alzheimer's disease and normal aging by EEG data Electroencephalogr Clin Neurophysiol 103 1997 241 248
154. J. Dauwels, F. Vialatte, and A. Cichocki Diagnosis of Alzheimer's disease from EEG signals: where are we standing? Curr Alzheimer Res 7 2010 487 505
155. W.S. Pritchard, D.W. Duke, K.L. Coburn, and N.C. Moore EEG-based, neural-net predictive classification of Alzheimer's disease versus control subjects is augmented by non-linear EEG measures Electroencephalogr Clin Neurophysiol 91 1994 118 130
156. T. Dierks, L. Frohlich, R. Ihl, and K. Maurer Correlation between cognitive brain-function and electrical brain activity in dementia of Alzheimer-type J Neural Transm Gen Sect 99 1995 55 62
157. C. Babiloni, G. Binetti, E. Cassetta, D. Cerboneschi, G. Dal Forno, and C. Del Percio Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study Neuroimage 22 2004 57 67
158. N. Tsuno, M. Shigeta, K. Hyoki, P.L. Faber, and D. Lehmann Fluctuations of source locations of EEG activity during transition from alertness to sleep in Alzheimer's disease and vascular dementia Neuropsychobiology 50 2004 267 272
159. D.V. Moretti, D. Paternicò, and G. Binetti EEG upper/low alpha frequency power ratio relates to temporo-parietal brain atrophy and memory performances in mild cognitive impairment Front Aging Neurosci 5 2013 63
160. S.-S. Poil, W. de Haan, W.M. van der Flier, H.D. Mansvelder, P. Scheltens, and K. Linkenkaer-Hansen Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage Front Aging Neurosci 5 2013 58
161. M. Elgendi, F. Vialatte, A. Cichocki, C. Latchoumane, J. Jeong, and J. Dauwels Optimization of EEG frequency bands for improved diagnosis of Alzheimer disease Conf Proc IEEE Eng Med Biol Soc 2011 2011 6087 6091
162. M.T. Schmidt, P.A. Kanda, L.F.H. Basile, H.F. da Silva Lopes, R. Baratho, and J.L. Demario Index of alpha/theta ratio of the electroencephalogram: a new marker for Alzheimer's disease Front Aging Neurosci 5 2013 60
163. A.A. Petrosian, D.V. Prokhorov, W. Lajara-Nanson, and R.B. Schiffer Recurrent neural network-based approach for early recognition of Alzheimer's disease in EEG Clin Neurophysiol 112 2001 1378 1387
164. F. Vialatte, A. Cichocki, G. Dreyfus, T. Musha, S.L. Shishkin, and R. Gervais Early detection of Alzheimer's disease by blind source separation, time frequency representation, and bump modeling of EEG signals. Lecture Notes in Computer Science 3696 2005 Springer Berlin Heidelberg Berlin, Heidelberg 683 692
165. A. Cichocki, S.L. Shishkin, T. Musha, Z. Leonowicz, T. Asada, and T. Kurachi EEG filtering based on blind source separation (BSS) for early detection of Alzheimer's disease Clin Neurophysiol 116 2005 729 737
166. C. Melissant, A. Ypma, E.E. Frietman, and C.J. Stam A method for detection of Alzheimer's disease using ICA-enhanced EEG measurements Artif Intell Med 33 2005 209 222
167. J. Jeong EEG dynamics in patients with Alzheimer's disease Clin Neurophysiol 115 2004 1490 1505
168. C. Lehmann, T. Koenig, V. Jelic, L. Prichep, R.E. John, and L.O. Wahlund Application and comparison of classification algorithms for recognition of Alzheimer's disease in electrical brain activity (EEG) J Neurosci Methods 161 2007 342 350
169. M. Buscema, P. Rossini, C. Babiloni, and E. Grossi The IFAST model, a novel parallel nonlinear EEG analysis technique, distinguishes mild cognitive impairment and Alzheimer's disease patients with high degree of accuracy Artif Intell Med 40 2007 127 141
170. P.M. Rossini, M. Buscema, M. Capriotti, E. Grossi, G. Rodriguez, and C. Del Percio Is it possible to automatically distinguish resting EEG data of normal elderly vs. mild cognitive impairment subjects with high degree of accuracy? Clin Neurophysiol 119 2008 1534 1545
171. M. Buscema, E. Grossi, M. Capriotti, C. Babiloni, and P. Rossini The I.F.A.S.T. model allows the prediction of conversion to Alzheimer disease in patients with mild cognitive impairment with high degree of accuracy Curr Alzheimer Res 7 2010 173 187
172. D. Cohen Magnetoencephalography - evidence of magnetic fields produced by alpha-rhythm currents Science 161 1968 784 786
173. Y.C. Okada, A. Lahteenmäki, and C. Xu Experimental analysis of distortion of magnetoencephalography signals by the skull Clin Neurophysiol 110 1999 230 238
174. A. Silver, and J. Zimmerman Quantum transitions and loss in multiply connected superconductors Phys Rev Lett 15 1965 888 891
175. L. Troebinger, J.D. López, A. Lutti, D. Bradbury, S. Bestmann, and G. Barnes High precision anatomy for MEG Neuroimage 2013
176. Robinson SE, Vrba J. Functional neuroimaging by synthetic aperture magnetometry (SAM). In: Recent Advances in Biomagnetism. Sendai: Tohoku University Press; 1999. p. 302-5.
177. H.W. Berendse, J.P. Verbunt, P. Scheltens, B.W. van Dijk, and E.J. Jonkman Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study Clin Neurophysiol 111 2000 604 612
178. A. Fernández, R. Hornero, A. Mayo, J. Poza, F. Maestú, and T. Ortiz Alonso Quantitative magnetoencephalography of spontaneous brain activity in Alzheimer disease: an exhaustive frequency analysis Alzheimer Dis Assoc Disord 20 2006 153 159
179. W. de Haan, C.J. Stam, B.F. Jones, I.M. Zuiderwijk, B.W. van Dijk, and P. Scheltens Resting-state oscillatory brain dynamics in Alzheimer disease J Clin Neurophysiol 25 2008 187 193
180. P. Riekkinen, G. Buzsaki, P. Riekkinen, H. Soininen, and J. Partanen The cholinergic system and EEG slow waves Electroencephalogr Clin Neurophysiol 78 1991 89 96
181. A. Fernández, F. Maestú, C. Amo, P. Gil, T. Fehr, and C. Wienbruch Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography Biol Psychiatry 52 2002 764 770
182. J. Poza, R. Hornero, J. Escudero, A. Fernández, and C.I. Sánchez Regional analysis of spontaneous MEG rhythms in patients with Alzheimer's disease using spectral entropies Ann Biomed Eng 36 2008 141 152
183. A. Fernández, J.M. García-Segura, T. Ortiz, J. Montoya, F. Maestú, and P. Gil-Gregorio Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease Dement Geriatr Cogn Disord 20 2005 169 177
184. A. Fernández, A. Turrero, P. Zuluaga, P. Gil-Gregorio, F. del-Pozo, and F. Maestú MEG delta mapping along the healthy aging-Alzheimer's disease continuum: diagnostic implications J Alzheimers Dis 35 2013 495 507
185. J.F. Alonso, J. Poza, M.A. Mañanas, S. Romero, A. Fernández, and R. Hornero MEG connectivity analysis in patients with Alzheimer's disease using cross mutual information and spectral coherence Ann Biomed Eng 39 2011 524 536
186. C.J. Stam, G. Nolte, and A. Daffertshofer Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources Hum Brain Mapp 28 2007 1178 1193
187. J.M. Buldú, R. Bajo, F. Maestú, N. Castellanos, I. Leyva, and P. Gil Reorganization of functional networks in mild cognitive impairment PLoS One 6 2011
188. S.R. Soekadar, M. Witkowski, E.G. Cossio, N. Birbaumer, S.E. Robinson, and L.G. Cohen In vivo assessment of human brain oscillations during application of transcranial electric currents Nat Commun 4 2013 2032
189. B. Inglis, K. Buckenmaier, P. Sangiorgio, A.F. Pedersen, M.A. Nichols, and J. Clarke MRI of the human brain at 130 microtesla Proc Natl Acad Sci U S A 110 2013 19194 19201
190. T.H. Sander, J. Preusser, and R. Mhaskar Magnetoencephalography with a chip-scale atomic magnetometer Biomed Opt Express 3 2012 981 990
191. R. Camicioli, D. Howieson, B. Oken, G. Sexton, and J. Kaye Motor slowing precedes cognitive impairment in the oldest old Neurology 50 1998 1496 1498
192. T. Buracchio, H.H. Dodge, D. Howieson, D. Wasserman, and J. Kaye The trajectory of gait speed preceding mild cognitive impairment Arch Neurol 67 2010 980 986
193. R.J. Bateman, P.S. Aisen, B. De Strooper, N.C. Fox, C.A. Lemere, and J.M. Ringman Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease Alzheimers Res Ther 3 2011 1
194. Praat: doing phonetics by computer. Available at: http://www.fon.hum.uva.nl/praat/ Accessed November 27, 2013.